Literature DB >> 29676010

Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease.

P Pavlidis1, J Graham2, S Gulati1, P Dubois1, M Heneghan2, D Joshi2, B Hayee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29676010     DOI： 10.1111/apt.14603

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  1 in total

1.  Aberrant hepatic trafficking of gut-derived T cells is not specific to primary sclerosing cholangitis.

Authors:  Jonathon J Graham; Sujit Mukherjee; Muhammad Yuksel; Rebeca Sanabria Mateos; Tengfei Si; Zhenlin Huang; Xiahong Huang; Hadil Abu Arqoub; Vishal Patel; Mark McPhail; Yoh Zen; Nigel Heaton; Maria Serena Longhi; Michael A Heneghan; Rodrigo Liberal; Diego Vergani; Giorgina Mieli-Vergani; Yun Ma; Bu'Hussain Hayee
Journal:  Hepatology       Date:  2021-12-07       Impact factor: 17.425
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.